149 related articles for article (PubMed ID: 11463812)
1. The insert region of RhoA is essential for Rho kinase activation and cellular transformation.
Zong H; Kaibuchi K; Quilliam LA
Mol Cell Biol; 2001 Aug; 21(16):5287-98. PubMed ID: 11463812
[TBL] [Abstract][Full Text] [Related]
2. Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion.
Guo F; Zheng Y
Oncogene; 2004 Jul; 23(33):5577-85. PubMed ID: 15122327
[TBL] [Abstract][Full Text] [Related]
3. RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation.
Sahai E; Alberts AS; Treisman R
EMBO J; 1998 Mar; 17(5):1350-61. PubMed ID: 9482732
[TBL] [Abstract][Full Text] [Related]
4. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
Palmby TR; Abe K; Karnoub AE; Der CJ
Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of cyclooxygenase 2 expression by small GTPases Ras, Rac1, and RhoA.
Chang YW; Putzer K; Ren L; Kaboord B; Chance TW; Qoronfleh MW; Jakobi R
J Cell Biochem; 2005 Oct; 96(2):314-29. PubMed ID: 16088958
[TBL] [Abstract][Full Text] [Related]
6. Effector domain mutants of Rho dissociate cytoskeletal changes from nuclear signaling and cellular transformation.
Zohar M; Teramoto H; Katz BZ; Yamada KM; Gutkind JS
Oncogene; 1998 Aug; 17(8):991-8. PubMed ID: 9747878
[TBL] [Abstract][Full Text] [Related]
7. The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways.
Martin CB; Mahon GM; Klinger MB; Kay RJ; Symons M; Der CJ; Whitehead IP
Oncogene; 2001 Apr; 20(16):1953-63. PubMed ID: 11360179
[TBL] [Abstract][Full Text] [Related]
8. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
Du J; Jiang B; Coffey RJ; Barnard J
Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
[TBL] [Abstract][Full Text] [Related]
9. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
Ulkü AS; Schäfer R; Der CJ
Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
[TBL] [Abstract][Full Text] [Related]
10. Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: Evidence for Rho kinase pathway.
Shah V; Bharadwaj S; Kaibuchi K; Prasad GL
Oncogene; 2001 Apr; 20(17):2112-21. PubMed ID: 11360195
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
12. Rho family proteins and Ras transformation: the RHOad less traveled gets congested.
Zohn IM; Campbell SL; Khosravi-Far R; Rossman KL; Der CJ
Oncogene; 1998 Sep; 17(11 Reviews):1415-38. PubMed ID: 9779988
[TBL] [Abstract][Full Text] [Related]
13. Stability of p21Waf1/Cip1 CDK inhibitor protein is responsive to RhoA-mediated regulation of the actin cytoskeleton.
Coleman ML; Densham RM; Croft DR; Olson MF
Oncogene; 2006 May; 25(19):2708-16. PubMed ID: 16407839
[TBL] [Abstract][Full Text] [Related]
14. CrkII induces serum response factor activation and cellular transformation through its function in Rho activation.
Iwahara T; Akagi T; Shishido T; Hanafusa H
Oncogene; 2003 Sep; 22(38):5946-57. PubMed ID: 12955073
[TBL] [Abstract][Full Text] [Related]
15. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
Fiordalisi JJ; Keller PJ; Cox AD
Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
[TBL] [Abstract][Full Text] [Related]
16. TGFbeta3-induced activation of RhoA/Rho-kinase pathway is necessary but not sufficient for epithelio-mesenchymal transdifferentiation: implications for palatogenesis.
Kaartinen V; Haataja L; Nagy A; Heisterkamp N; Groffen J
Int J Mol Med; 2002 Jun; 9(6):563-70. PubMed ID: 12011971
[TBL] [Abstract][Full Text] [Related]
17. Critical role of Rho in cell transformation by oncogenic Ras.
Prendergast GC; Khosravi-Far R; Solski PA; Kurzawa H; Lebowitz PF; Der CJ
Oncogene; 1995 Jun; 10(12):2289-96. PubMed ID: 7784077
[TBL] [Abstract][Full Text] [Related]
18. Molecular decipherment of Rho effector pathways regulating tight-junction permeability.
Fujita H; Katoh H; Hasegawa H; Yasui H; Aoki J; Yamaguchi Y; Negishi M
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):617-22. PubMed ID: 10698687
[TBL] [Abstract][Full Text] [Related]
19. RhoE inhibits cell cycle progression and Ras-induced transformation.
Villalonga P; Guasch RM; Riento K; Ridley AJ
Mol Cell Biol; 2004 Sep; 24(18):7829-40. PubMed ID: 15340047
[TBL] [Abstract][Full Text] [Related]
20. Serine phosphorylation differentially affects RhoA binding to effectors: implications to NGF-induced neurite outgrowth.
Nusser N; Gosmanova E; Makarova N; Fujiwara Y; Yang L; Guo F; Luo Y; Zheng Y; Tigyi G
Cell Signal; 2006 May; 18(5):704-14. PubMed ID: 16109481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
